Digital twin technology to improve liver disease care
Part of Digestive system, Hormones & metabolism clinical trials.
This study uses digital twin technology (a computer model of your health) to improve early detection, personalized treatment, and long-term monitoring for people with liver disease. It includes different groups focusing on fatty liver disease, cirrhosis, and liver cancer, and aims to help doctors predict and manage complications like heart problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You need a diagnosis of liver disease, such as fatty liver disease, cirrhosis, or liver cancer.
- Depending on the group, you may need to have had imaging or a biopsy of your liver, and at least one follow-up a year later.
- You should not have certain other conditions like active hepatitis B or C, or other causes of liver disease, depending on the group.
- You may need to have no known heart disease or have controlled blood pressure if you have hypertension.
- For certain groups, you must have had a TIPS procedure or a liver transplant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a digital diet and exercise program to help reduce liver scarring in people with fatty liver disease. You'll use an app or online tool to follow healthy eating and activity routines, which may slow or reverse liver damage.
This study aims to build a tool to predict how MASLD-related cirrhosis (fatty liver disease leading to liver scarring) will progress. It may help doctors and patients better understand the outlook and plan care.
This study is testing whether advanced imaging and other non-invasive methods can properly identify people with significant liver scarring due to metabolic liver disease or alcohol-related liver disease. It may help find better ways to track liver health without repeated needle biopsies.
This study tests a new screening tool to find advanced liver scarring in people with liver disease linked to diabetes. It helps doctors decide who needs more tests or specialist care.
This study uses routine blood tests to find people with advanced liver scarring caused by a condition called MASLD. If you are between 50 and 75, have certain metabolic risks, and get blood work from your primary care doctor at select centers, you may be eligible.
This study looks at factors that predict liver cancer and the need for a liver transplant in people with a liver condition called MASLD (metabolic dysfunction-associated steatotic liver disease). The goal is to better understand the disease and improve care.
Hear when a new Metabolic Dysfunction-Associated Steatotic Liver Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.